VERSEAU THERAPEUTICS
Verseau is creating a new class of therapeutics, macrophage checkpoint modulators, to benefit patients with cancer, immune and inflammatory diseases. The company's modulators identify novel targets and develop therapies that shift macrophages between immune activators and silencers in disease, enabling physicians to benefit patients from immunotherapy.
VERSEAU THERAPEUTICS
Industry:
Biotechnology Therapeutics
Founded:
2017-01-01
Address:
Bedford, Massachusetts, United States
Country:
United States
Website Url:
http://www.verseautx.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
54.3 M USD
Technology used in webpage:
CrUX Top 50m CrUX Dataset
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Cellestia
Cellestia is a clinical stage R&D company developing innovative first-in-class therapies to control and modulate pathogenic gene expression.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Jounce Therapeutics
Jounce Therapeutics is developing cancer immune-therapies to harness the immune system to attack cancerous cells and tumors.
Current Employees Featured
Founder
Investors List
Alexandria Venture Investments
Alexandria Venture Investments investment in Venture Round - Verseau Therapeutics
Highlight Capital
Highlight Capital investment in Venture Round - Verseau Therapeutics
3SBio Inc.
3SBio Inc. investment in Venture Round - Verseau Therapeutics
Yonghua Capital
Yonghua Capital investment in Venture Round - Verseau Therapeutics
InHarv Partners
InHarv Partners investment in Venture Round - Verseau Therapeutics
The Mark Foundation for Cancer Research
The Mark Foundation for Cancer Research investment in Venture Round - Verseau Therapeutics
20/20 HealthCare Partners
20/20 HealthCare Partners investment in Venture Round - Verseau Therapeutics
Key Employee Changes
Official Site Inspections
http://www.verseautx.com Semrush global rank: 11.53 M Semrush visits lastest month: 156
- Host name: 48.182.174.34.bc.googleusercontent.com
- IP address: 34.174.182.48
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Verseau Therapeutics"
Homepage – Verseau Therapeutics
At Verseau, we are advancing a new class of cancer immunotherapies to stimulate the conversion of immuno-suppressive and pro-tumorigenic M2 macrophages into pro-inflammatory M1 …See details»
About – Verseau Therapeutics
Verseau Therapeutics was founded in 2017 by Bob Langer, Dan Anderson, Tatiana Novobrantseva and Igor Feldman to discover and develop a broad pipeline of novel …See details»
Verseau Therapeutics - Crunchbase Company Profile & Funding
Verseau focus is building a pipeline of first-in-class therapies that modulate macrophages to trigger a coordinated immune attack on cancer. View contacts for Verseau Therapeutics to …See details»
Verseau Therapeutics - LinkedIn
Verseau is focused on developing the next major wave of cancer immunotherapies directed at a broad and potent reprogramming of the tumor microenvironment to attack tumors.See details»
Verseau Therapeutics - Overview, News & Similar companies
Jan 3, 2022 · View Verseau Therapeutics (www.verseautx.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well …See details»
Contact - Verseau Therapeutics
Images are courtesy of Advanced Optical Microscopy Unit, Humanitas Research Labs, Istituto Clinico Humanitas.See details»
Verseau Therapeutics Announces FDA Clearance of …
Jan 4, 2022 · VTX-0811 repolarizes macrophages, leading to coordinated anti-tumor immune responses. The FDA has completed its 30-day safety review and granted approval for the company to proceed with the...See details»
Verseau Therapeutics Company Overview, Contact Details
Oct 21, 2019 · Verseau Therapeutics 's official website is verseautx.com and has social profiles on LinkedIn. How much revenue does Verseau Therapeutics generate? As of September 2024 …See details»
Verseau Therapeutics - Work in biotech
Verseau Therapeutics aims to develop a new class of immunotherapy treatments for cancer. Their scientific approach centers on repolarizing immune cells, macrophages, from an immuno …See details»
Verseau Therapeutics - Craft
Verseau Therapeutics is a company that develops macrophage checkpoint modulators designed to benefit patients with cancer, immune and inflammatory diseases.See details»
Verseau Therapeutics Appoints Tim Smith as Chief Business Officer
Nov 13, 2019 · In this newly created executive position, Mr. Smith is responsible for business development, corporate development and investor relations as Verseau advances its novel …See details»
Verseau Therapeutics Appoints John Edwards as Chief Executive …
Verseau is focused on developing the next major wave of cancer immunotherapies directed at a broad and potent reprogramming of the tumor microenvironment to attack tumors.See details»
Verseau Therapeutics - VentureRadar
Website: http://verseautx.com/ Develops macrophage checkpoint modulators for the treatment of cancer, immune and inflammatory diseases, aiming to enhance the benefits from …See details»
Verseau Therapeutics, Inc. (Verseau Therapeutics, Inc.) - 药物管线_ …
美赛生物是国内首家专注于肿瘤微环境中巨噬细胞全新靶点的生物药开发的新兴生物技术企业，针对巨噬细胞的药物可以增强巨噬细胞对肿瘤细胞的吞噬，募集和活化下游的效应T细胞，实现 …See details»
Verseau Therapeutics Appoints John Edwards as Chief Executive …
May 26, 2021 · Verseau is focused on developing the next major wave of cancer immunotherapies directed at a broad and potent reprogramming of the tumor …See details»
_______________________________________________________________________
Verseau is developing novel, first-in-class immunotherapies that target modulation of macrophages, the master orchestrators of the immune system. The proceeds from the …See details»
Meta Developers - Oculus VR
Manage your organization. Create your organization. Add financial settings. Get financial reports. Verify your org. Manage multiple orgs. Manage test users. Business models and strategy. …See details»
Log in to your Okta org
Not yet an Okta customer? If you don’t have an Okta organization or credentials, use the Okta Digital Experience Account to get access to Learning Portal, Help Center, Certification, …See details»
Press release - verseautx.com
Verseau’s proprietary drug discovery platform generates first-in-class macrophage checkpoint modulators (MCMs) to benefit patients with cancer, immune and inflammatory diseases.See details»
Verseau Therapeutics Announces FDA Clearance of Investigational …
For its lead investigational product candidate, VTX-0811, a monoclonal antibody that. binds to P-selectin glycoprotein ligand-1 (PSGL-1). VTX-0811 repolarizes macrophages, leading to …See details»